Targeting the sulfur-containing amino acid pathway in leukemia
[1] [7] Additionally, metabolic changes and adjustment to improved blood glucose control may temporarily affect energy levels
Safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of a dual GLP-1/GIP receptor agonist (HRS9531) in T2DM patients: a randomized, double-blind, placebo- and open-label positive-controlled phase 1b trial
Always consult a qualified healthcare provider before starting any new treatment
A provider can evaluate your health history, metabolic profile, and weight-loss goals to determine whether this therapy aligns with your long-term plan for improved health and sustainability
Two other drug makers are also working on generic Victoza: Sandoz and Viatris (formerly Mylan)